Over the last 7 days, the Biotech industry has remained flat, although notably ALTEOGEN gained 10%. Unfortunately though, the industry is down 6.1% over the past 12 months. Looking forward, earnings are forecast to grow by 17% annually.
Has the South Korean Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Wed, 29 Nov 2023 | ₩59.0t | ₩10.1t | -₩315,765,649,899.00 | 26.1x | -186.7x | 5.8x |
Fri, 27 Oct 2023 | ₩52.2t | ₩10.2t | -₩239,053,318,689.00 | 27.8x | -218.4x | 5.1x |
Sun, 24 Sep 2023 | ₩55.7t | ₩10.2t | -₩239,053,318,689.00 | 28.8x | -233.1x | 5.5x |
Tue, 22 Aug 2023 | ₩57.5t | ₩10.2t | -₩213,622,992,279.00 | 36.8x | -269.1x | 5.6x |
Thu, 20 Jul 2023 | ₩56.4t | ₩10.3t | -₩151,534,704,579.00 | 25.9x | -372.4x | 5.5x |
Sat, 17 Jun 2023 | ₩60.8t | ₩10.3t | -₩151,534,704,579.00 | 29.8x | -401.1x | 5.9x |
Mon, 15 May 2023 | ₩61.2t | ₩11.0t | ₩317.8b | 26.5x | 192.5x | 5.6x |
Wed, 12 Apr 2023 | ₩63.3t | ₩11.0t | ₩318.9b | 24.2x | 198.4x | 5.7x |
Fri, 10 Mar 2023 | ₩58.8t | ₩11.3t | ₩964.4b | 25.6x | 61x | 5.2x |
Sun, 05 Feb 2023 | ₩61.6t | ₩11.3t | ₩970.8b | 25x | 63.5x | 5.4x |
Tue, 03 Jan 2023 | ₩58.1t | ₩11.4t | ₩685.0b | 23.2x | 84.8x | 5.1x |
Thu, 01 Dec 2022 | ₩60.4t | ₩10.8t | ₩189.9b | 23.8x | 317.9x | 5.6x |
Sat, 29 Oct 2022 | ₩59.7t | ₩10.8t | ₩348.0b | 19.1x | 171.4x | 5.5x |
Mon, 26 Sep 2022 | ₩57.4t | ₩10.8t | ₩391.5b | 20.9x | 146.7x | 5.3x |
Wed, 24 Aug 2022 | ₩68.6t | ₩10.8t | ₩617.8b | 23.3x | 111x | 6.3x |
Fri, 22 Jul 2022 | ₩70.5t | ₩10.7t | ₩597.6b | 26.6x | 117.9x | 6.6x |
Sun, 19 Jun 2022 | ₩61.4t | ₩10.6t | ₩627.1b | 23.4x | 97.9x | 5.8x |
Tue, 17 May 2022 | ₩63.7t | ₩10.0t | ₩871.1b | 25.8x | 73.1x | 6.4x |
Thu, 14 Apr 2022 | ₩72.0t | ₩10.0t | ₩898.1b | 27.6x | 80.1x | 7.2x |
Sat, 12 Mar 2022 | ₩75.1t | ₩9.4t | ₩746.5b | 34.8x | 100.7x | 8x |
Mon, 07 Feb 2022 | ₩75.6t | ₩9.4t | ₩787.4b | 33.5x | 96x | 8.1x |
Wed, 05 Jan 2022 | ₩91.3t | ₩9.4t | ₩787.4b | 39.1x | 116x | 9.7x |
Fri, 03 Dec 2021 | ₩94.0t | ₩9.4t | ₩790.0b | 41.4x | 119x | 10x |
Sun, 31 Oct 2021 | ₩94.4t | ₩9.2t | ₩988.3b | 38.5x | 95.5x | 10.2x |
Tue, 28 Sep 2021 | ₩115.3t | ₩9.2t | ₩986.1b | 43.2x | 116.9x | 12.5x |
Thu, 26 Aug 2021 | ₩118.8t | ₩9.3t | ₩909.7b | 50.7x | 130.6x | 12.8x |
Fri, 02 Jul 2021 | ₩106.9t | ₩9.3t | ₩909.7b | 53.7x | 117.5x | 11.5x |
Mon, 05 Apr 2021 | ₩103.5t | ₩9.0t | ₩979.0b | 41.2x | 105.7x | 11.5x |
Thu, 07 Jan 2021 | ₩107.7t | ₩8.2t | ₩501.3b | 54.1x | 214.9x | 13.1x |
404.2x
How does South Korean Biotech compare with similar industries?
KR Market | 0.36% | |
Healthcare | -0.33% | |
Biotech | -0.41% | |
Biotech | -0.41% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
A196170 ALTEOGEN | ₩78.60k | 6.9% +₩263.9b | 114.5% | PE629.8x | |
A215600 SillaJen | ₩6.62k | 51.1% +₩230.3b | -31.6% | PS111.7x | |
A199800 ToolGen | ₩78.10k | 28.7% +₩137.8b | 49.3% | PS951.7x | |
A310210 Voronoi | ₩41.80k | 9.7% +₩61.7b | 84.4% | PS1183.9x | |
A086900 Medy-Tox | ₩223.50k | 4.0% +₩57.2b | 96.2% | PE145.4x |